28205317|t|Oxidative stress and immunosenescence in spleen of obese mice can be reversed by 2-hydroxyoleic acid
28205317|a|We aimed to investigate the effects of obesity on oxidative stress and leukocyte function in spleen of mice, and to assess whether supplementation with 2-hydroxyoleic acid (2-OHOA) or n-3 polyunsaturated fatty acids (PUFA) could reverse those effects. Female ICR/CD1 mice (8 weeks old, n = 24) received an obesogenic diet (22% fat for 4 weeks and 60% fat for 14 weeks). After 6 weeks, mice were split in three groups (n = 8/ group): no supplementation, 2-OHOA supplementation (1500 mg kg(-1)) and n-3 PUFA supplementation (EPA + DHA, 3000 mg kg(-1) diet). Eight mice were fed standard diet for the whole duration of the study (control group). At the end of the experiment, the following variables were assessed in spleens: levels of reduced (GSH) and oxidized (GSSG) glutathione, GSH / GSSG, xanthine oxidase (XO) activity, lipid peroxidation, lymphocyte chemotaxis, natural killer (NK) activity and mitogen (ConA and LPS)-induced lymphocyte proliferation. Obese animals presented higher GSSG levels (P = 0.003), GSSG / GSH ratio (P = 0.013), lipid peroxidation (P = 0.004), XO activity (P = 0.015) and lymphocyte chemotaxis (P < 0.001), and lower NK activity (P = 0.003) and proliferation in response to ConA (P < 0.001) than controls. 2-OHOA reversed totally or partially most of the changes (body weight, fat content, GSSG levels, GSH / GSSG, lipid peroxidation, chemotaxis and proliferation, all P < 0.05), while n-3 PUFA reversed the increase in XO activity (P = 0.032). In conclusion, 2-OHOA, and to a lesser extent n-3 PUFA, could ameliorate the oxidative stress and alteration of leukocyte function in spleen of obese mice. Our findings support a link between obesity and immunosenescence and suggest a potential therapeutic tool for obesity -related immune dysfunction. This article is protected by copyright. All rights reserved.
28205317	0	16	Oxidative stress	T038	UMLS:C0242606
28205317	21	37	immunosenescence	T038	UMLS:C0596761
28205317	41	47	spleen	T017	UMLS:C0037993
28205317	51	61	obese mice	T204	UMLS:C0025933
28205317	81	100	2-hydroxyoleic acid	T103	UMLS:C1436659
28205317	140	147	obesity	T038	UMLS:C0028754
28205317	151	167	oxidative stress	T038	UMLS:C0242606
28205317	172	181	leukocyte	T017	UMLS:C0023516
28205317	182	190	function	T038	UMLS:C0007613
28205317	194	200	spleen	T017	UMLS:C0037993
28205317	204	208	mice	T204	UMLS:C0025929
28205317	232	247	supplementation	T058	UMLS:C0242297
28205317	253	272	2-hydroxyoleic acid	T103	UMLS:C1436659
28205317	274	280	2-OHOA	T103	UMLS:C1436659
28205317	285	316	n-3 polyunsaturated fatty acids	T103	UMLS:C0015689
28205317	318	322	PUFA	T103	UMLS:C0015689
28205317	360	372	ICR/CD1 mice	T204	UMLS:C2697641
28205317	407	422	obesogenic diet	T168	UMLS:C0012155
28205317	428	431	fat	T103	UMLS:C0012171
28205317	452	455	fat	T103	UMLS:C0012171
28205317	486	490	mice	T204	UMLS:C0025929
28205317	624	627	EPA	T103	UMLS:C0000545
28205317	630	633	DHA	T103	UMLS:C0556150
28205317	663	667	mice	T204	UMLS:C0025929
28205317	686	690	diet	T168	UMLS:C0012155
28205317	721	726	study	T062	UMLS:C2603343
28205317	762	772	experiment	T062	UMLS:C0681814
28205317	815	822	spleens	T017	UMLS:C0037993
28205317	834	841	reduced	T103	UMLS:C0017817
28205317	843	846	GSH	T103	UMLS:C0017817
28205317	852	879	oxidized (GSSG) glutathione	T103	UMLS:C0061516
28205317	881	884	GSH	T103	UMLS:C0017817
28205317	887	891	GSSG	T103	UMLS:C0061516
28205317	893	923	xanthine oxidase (XO) activity	T038	UMLS:C1151293
28205317	925	943	lipid peroxidation	T038	UMLS:C0023775
28205317	945	966	lymphocyte chemotaxis	T038	UMLS:C0312862
28205317	968	996	natural killer (NK) activity	T038	UMLS:C1317556
28205317	1001	1008	mitogen	T103	UMLS:C0026249
28205317	1010	1014	ConA	T103	UMLS:C0009630
28205317	1019	1022	LPS	T103	UMLS:C0023810
28205317	1032	1056	lymphocyte proliferation	T038	UMLS:C0596873
28205317	1064	1071	animals	T204	UMLS:C0003062
28205317	1089	1093	GSSG	T103	UMLS:C0061516
28205317	1114	1118	GSSG	T103	UMLS:C0061516
28205317	1121	1124	GSH	T103	UMLS:C0017817
28205317	1144	1162	lipid peroxidation	T038	UMLS:C0023775
28205317	1176	1187	XO activity	T038	UMLS:C1151293
28205317	1204	1225	lymphocyte chemotaxis	T038	UMLS:C0312862
28205317	1249	1260	NK activity	T038	UMLS:C1317556
28205317	1306	1310	ConA	T103	UMLS:C0009630
28205317	1338	1344	2-OHOA	T103	UMLS:C1436659
28205317	1422	1426	GSSG	T103	UMLS:C0061516
28205317	1435	1438	GSH	T103	UMLS:C0017817
28205317	1441	1445	GSSG	T103	UMLS:C0061516
28205317	1447	1465	lipid peroxidation	T038	UMLS:C0023775
28205317	1467	1477	chemotaxis	T038	UMLS:C0008018
28205317	1482	1495	proliferation	T038	UMLS:C0596290
28205317	1518	1526	n-3 PUFA	T103	UMLS:C0015689
28205317	1552	1563	XO activity	T038	UMLS:C1151293
28205317	1592	1598	2-OHOA	T103	UMLS:C1436659
28205317	1623	1631	n-3 PUFA	T103	UMLS:C0015689
28205317	1654	1670	oxidative stress	T038	UMLS:C0242606
28205317	1689	1698	leukocyte	T017	UMLS:C0023516
28205317	1699	1707	function	T038	UMLS:C0007613
28205317	1711	1717	spleen	T017	UMLS:C0037993
28205317	1721	1731	obese mice	T204	UMLS:C0025933
28205317	1737	1745	findings	T033	UMLS:C0243095
28205317	1769	1776	obesity	T038	UMLS:C0028754
28205317	1781	1797	immunosenescence	T038	UMLS:C0596761
28205317	1843	1850	obesity	T038	UMLS:C0028754
28205317	1860	1878	immune dysfunction	T038	UMLS:C0021053